Autotransfusion System (ATS) is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures. Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
This report contains market size and forecasts of Autotransfusion Systems (ATS) in global, including the following market information:
Global Autotransfusion Systems (ATS) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Autotransfusion Systems (ATS) Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Autotransfusion Systems (ATS) companies in 2021 (%)
The global Autotransfusion Systems (ATS) market was valued at 436.1 million in 2021 and is projected to reach US$ 574.6 million by 2028, at a CAGR of 4.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Continuous Autotransfusion Systems Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Autotransfusion Systems (ATS) include BD (Bard), LivaNova, Fresenius Kabi, Haemonetics and Medtronic, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Autotransfusion Systems (ATS) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Autotransfusion Systems (ATS) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Autotransfusion Systems (ATS) Market Segment Percentages, by Type, 2021 (%)
Continuous Autotransfusion Systems
Discontinuous Autotransfusion Systems
Global Autotransfusion Systems (ATS) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Autotransfusion Systems (ATS) Market Segment Percentages, by Application, 2021 (%)
Cardiac Surgery
Non-Cardiac Surgery
Global Autotransfusion Systems (ATS) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Autotransfusion Systems (ATS) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Autotransfusion Systems (ATS) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Autotransfusion Systems (ATS) revenues share in global market, 2021 (%)
Key companies Autotransfusion Systems (ATS) sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Autotransfusion Systems (ATS) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
BD (Bard)
LivaNova
Fresenius Kabi
Haemonetics
Medtronic